Employees: 03 (2023.0)Legal category: SCA (commandite par actions)Size: PMECreation date: 2009-12-24 (16 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MENTON (06500), Alpes-Maritimes
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELAS PHARMACIE SANSON COLOMBANI is a French company
founded 16 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MENTON (06500),
this company of category PME
shows in 2016 a revenue of 2.0 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELAS PHARMACIE SANSON COLOMBANI (SIREN 519064117)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
2 003 883 €
Net income
16 355 €
19 957 €
43 330 €
85 097 €
61 876 €
61 335 €
148 599 €
163 231 €
-120 960 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
223 169 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
-6.0%
Revenue and income statement
In 2024, SELAS PHARMACIE SANSON COLOMBANI generates positive net income of 16 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
16 355 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 120%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 37%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
120.05%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
36.887%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
577.476
334.435
234.989
201.451
228.93
188.964
157.791
136.404
120.05
Financial autonomy
12.486
18.829
25.171
26.881
25.851
29.587
31.791
32.887
36.887
Repayment capacity
9.97
None
None
None
None
None
None
None
None
Cash flow / Revenue
8.082%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
120.052024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average
In 2024, the debt ratio of SELAS PHARMACIE SANSON CO... (120.05) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
36.89%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+5 pts over 3 years
In 2024, the financial autonomy of SELAS PHARMACIE SANSON CO... (36.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 108.61. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
120.033
130.305
135.593
99.746
198.167
198.772
153.318
121.665
108.613
Interest coverage
22.744
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
108.612024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Watch-7 pts over 3 years
In 2024, the liquidity ratio of SELAS PHARMACIE SANSON CO... (108.61) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELAS PHARMACIE SANSON COLOMBANI
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
423 501 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
39
0
0
0
0
0
0
0
0
Customer payment term (days)
21
0
0
0
0
0
0
0
0
Supplier payment term (days)
76
0
0
0
0
0
0
0
0
Positioning of SELAS PHARMACIE SANSON COLOMBANI in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELAS PHARMACIE SANSON COLOMBANI is estimated at
228 327 €
(range 159 003€ - 341 591€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
159k€228k€341k€
228 327 €Range: 159 003€ - 341 591€
NAF 5 année 2024
Valuation method used
Net Income Multiple
16 355 €
×
14.0x
=228 328 €
Range: 159 004€ - 341 592€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELAS PHARMACIE SANSON COLOMBANI with other companies in the same sector:
Frequently asked questions about SELAS PHARMACIE SANSON COLOMBANI
What is the revenue of SELAS PHARMACIE SANSON COLOMBANI ?
The revenue of SELAS PHARMACIE SANSON COLOMBANI in 2016 is 2.0 M€.
Is SELAS PHARMACIE SANSON COLOMBANI profitable?
Yes, SELAS PHARMACIE SANSON COLOMBANI generated a net profit of 16 k€ in 2024.
Where is the headquarters of SELAS PHARMACIE SANSON COLOMBANI ?
The headquarters of SELAS PHARMACIE SANSON COLOMBANI is located in MENTON (06500), in the department Alpes-Maritimes.
Where to find the tax return of SELAS PHARMACIE SANSON COLOMBANI ?
The tax return of SELAS PHARMACIE SANSON COLOMBANI is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELAS PHARMACIE SANSON COLOMBANI operate?
SELAS PHARMACIE SANSON COLOMBANI operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart